Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV Vaccination Dosing in HIV-positive and High-Risk MSM
NCT03854630Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2017
- Primary completion
- Jun 2023
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03854630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854630.